butorphanol has been researched along with Muscle Contraction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eades, SC; Hosgood, GL; Moore, RM; Wooldridge, AA | 1 |
| Freas, W; Muldoon, S; Otto, J; Watson, RL | 1 |
| Hayes, A; Kelly, A | 1 |
| Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM | 1 |
4 other study(ies) available for butorphanol and Muscle Contraction
| Article | Year |
|---|---|
In vitro effects of oxytocin, acepromazine, detomidine, xylazine, butorphanol, terbutaline, isoproterenol, and dantrolene on smooth and skeletal muscles of the equine esophagus.
Topics: Acepromazine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analgesics, Opioid; Animals; Area Under Curve; Butorphanol; Dantrolene; Dopamine Antagonists; Electric Stimulation; Esophagus; Horses; Imidazoles; In Vitro Techniques; Isoproterenol; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle Relaxants, Central; Muscle, Skeletal; Muscle, Smooth; Oxytocin; Terbutaline; Xylazine | 2002 |
The effects of morphine, nalbuphine, and butorphanol on adrenergic function in canine saphenous veins.
Topics: Adrenergic alpha-Antagonists; Animals; Butorphanol; Dogs; In Vitro Techniques; Morphinans; Morphine; Muscle Contraction; Muscle, Smooth, Vascular; Nalbuphine; Norepinephrine; Saphenous Vein; Sympathetic Nervous System; Veins | 1983 |
Profile of activity of kappa receptor agonists in the rabbit vas deferens.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Benzodiazepines; Benzomorphans; Butorphanol; Cyclazocine; Ethylketocyclazocine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nalorphine; Naloxone; Pyrrolidines; Rabbits; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Vas Deferens | 1985 |
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu | 1987 |